These abnormalities include somatic mutations of KEAP1, somatic mutations or deletions of CUL3, and deletions of ATG7, which occur in 2–4%, 1–5% and 6% of ESCC cases, respectively [54]. This evidence concerns the gene KEAP1 and esophageal squamous cell carcinoma.